Abstract |
The true prevalence of neurosyphilis in HIV-infection is unknown, since a sufficiently sensitive and specific test is lacking. In a prospective study we found reactive serum TPHA and FTA-ABS IgG tests in 95 (31%) of 307 HIV-infected patients. Three of 11 patients with latent syphilis revealed reactive CSF-VDRL tests, six others only demonstrated CSF abnormalities. Resolution of CSF abnormalities during a six month follow up after high dose antibiotic therapy led to the diagnosis of oligosymptomatic or asymptomatic neurosyphilis in all nine patients. Thus, the specificity of the CSF-VDRL was 100%, but the sensitivity was only 33%. The overall prevalence of neurosyphilis was 2.9%, increasing to 9.5% in patients with a reactive serum TPHA. Our study emphasizes the importance of antibiotic therapy for presumptive neurosyphilis in HIV-infected patients with latent syphilis and CSF abnormalities but nonreactive CSF-VDRL tests, even if they are neurologically asymptomatic or present with complaints inconclusive of neurosyphilis.
|
Authors | R Malessa, M W Agelink, U Hengge, L Mertins, M Gastpar, N H Brockmeyer |
Journal | European journal of medical research
(Eur J Med Res)
Vol. 1
Issue 6
Pg. 299-302
(Mar 19 1996)
ISSN: 0949-2321 [Print] England |
PMID | 9367943
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Cardiolipins
- Penicillins
- Phosphatidylcholines
- VDRL antigen
- Erythromycin
- Cholesterol
- Penicillin G
|
Topics |
- Adult
- Anti-Bacterial Agents
(therapeutic use)
- Cardiolipins
(cerebrospinal fluid)
- Cholesterol
(cerebrospinal fluid)
- Erythromycin
(therapeutic use)
- False Negative Reactions
- HIV Infections
(complications)
- HIV Seropositivity
(complications)
- Humans
- Male
- Middle Aged
- Neurosyphilis
(complications, diagnosis, drug therapy, epidemiology)
- Penicillin G
(therapeutic use)
- Penicillins
(therapeutic use)
- Phosphatidylcholines
(cerebrospinal fluid)
- Prevalence
- Reproducibility of Results
- Sensitivity and Specificity
|